EN DE
Watch Gasporox AB (publ) for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Gasporox AB (publ) (GPX) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Gasporox AB (publ) stock SEK 3.88, price SEK 4.60, that is 15.7% below the price, quality 27 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology SE · ISIN SE0008991624

GA Gasporox AB (publ) logo Thin data Nov 10, 2026

Gasporox AB (publ)

GPX · ST
Expensive, weak quality

Our calculation puts a fair price 16% below what the stock costs today.

Expensive Growth (revenue 5y +20.5 %/yr in SEK)
Moderate debt
Revenue last quarter 35% below a year ago.
Fair value kr 3.88 · Overvalued
Quality 27/100
Loss-making · -18.3% net margin (TTM)
Negative free cash flow
Trails peers (2/9)
Narrow moat 10/100 · thin data
Thin data
Estimate
Watch Gasporox AB (publ) for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 20.00 kr 4.40 Fair Value kr 3.88 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range kr 4.40 – kr 20.00 · fair‑value band kr 2.91 – kr 4.85 · the kr 4.60 price screens above the kr 3.88 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Gasporox AB (publ) in your weekly email

Every Wednesday you see whether Gasporox AB (publ) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden.

Show moreShow less

The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software.

It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, training, and customized accessories for the GPX1500.

Gasporox AB (publ) was incorporated in 2005 and is based in Lund, Sweden.

Stock analysis

Gasporox AB (publ) (GPX) currently trades at kr 4.60, while our estimate is kr 3.88, 16% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: kr 2.91 (bear) to kr 4.85 (bull), the price of kr 4.60 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 27/100 (below-average quality), in the Technology sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Gasporox AB (publ) reported revenue of 31.6M SEK in FY2025 versus 15.7M SEK in FY2021, a compound +19.0%/yr. Reported net income was −7.7M SEK in FY2025.

Key figures

Market cap 43.0M SEK (≈ $4.4M) Micro · P/S ratio 1.11 · EPS (TTM) kr −0.7300 · Net margin −18.3% · Return on equity −48.3% · Return on assets (EBIT) −9.3% (5-year average) · Operating margin −66.7% · Revenue (TTM) 40.1M SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).

What moves the price

The share trades about 50% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −46% fair-value upside, at −16%, GPX screens cheaper than that median.

Fair Value

Bear kr 2.91 Fair Value kr 3.88 Bull kr 4.85
Price kr 4.60 · Downside -15.7%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 27/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 8
How much profit the company makes from its sales and capital
Quality Growth 2
Are margins and returns getting better?
Cashflow 3
Do the profits arrive as real cash?
Financial strength 40
Debt, balance sheet and risk of trouble
Investment 69
Does it invest with discipline instead of growing at any price?
Low Volatility 42
How calm the share price moves, does not count
Price momentum 9
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 67
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−7.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.5%
Start year 2020 (pandemic). Over 10 years: +38.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+44.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−35.0% (2020) → −25.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

GPX screens overvalued: fair value 16% below the price. Compare with Keysight Technologies, Inc →

Compare Gasporox AB (publ) with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 180 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 27 · Bottom 25%
Fair Value upside −15.7% · Above median
Profitability
Return on assets −15.2% · Bottom 25%
Net margin (12 months) −18.3% · Bottom 25%
Operating margin (12 months) −66.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −34.7% · Bottom 25%
Balance sheet
Debt / equity 0.73× · Highest 25%

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/B 2.17× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 1.07× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)12 · sector 1
FUTURE (revenue growth)0 · sector 47
PAST (return on equity)0 · sector 20
HEALTH (low debt)64 · sector 98
DIVIDEND (yield)0 · sector 20

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Garmin Ltd GRMN $288.66 $320.98 +11% vs GPX
Teledyne Technologies Incorporated TDY $646.13 $680.46 +5% vs GPX
MKS Inc MKSI $213.47 $199.16 −7% vs GPX
Cognex Corporation CGNX $50.80 $38.10 −25% vs GPX
Trimble Inc TRMB $54.75 $29.48 −46% vs GPX
Fortive Corporation FTV $67.73 $35.67 −47% vs GPX
ESCO Technologies Inc ESE $238.38 $108.62 −54% vs GPX
Coherent Corp COHR $214.66 $92.93 −57% vs GPX
Keysight Technologies, Inc KEYS $291.46 $117.27 −60% vs GPX
AVIC Chengdu Aircraft Company 302132 ¥68.17 ¥12.60 −82% vs GPX

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Gasporox AB (publ): fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Gasporox AB (publ) Fair Value". https://www.fairvalue-calculator.com/stock/GPX

Frequently asked questions

Is Gasporox AB (publ) (GPX) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is kr 3.88 versus a price of kr 4.60, about 16% lower (overvalued).
What is the fair value of GPX?
Our estimate for Gasporox AB (publ) is kr 3.88 (as of Nov 10, 2026), built from audited fundamentals. The current price: kr 4.60.
What is the quality score of GPX?
Gasporox AB (publ) has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Gasporox AB (publ) (GPX)?
Our calculated price target is the estimate of kr 3.88 (as of Nov 10, 2026). Cautious scenario kr 2.91, optimistic scenario kr 4.85. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Gasporox AB (publ) stock forecast for 2026?
Our estimate puts fair value at kr 3.88, about 16% lower versus a price of kr 4.60 (overvalued). Cautious scenario kr 2.91, optimistic scenario kr 4.85. The calculation is refreshed regularly with new filings.
What is the revenue of Gasporox AB (publ) (GPX)?
Gasporox AB (publ) reported trailing-twelve-month revenue of about 40.1M SEK (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Gasporox AB (publ) (GPX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Gasporox AB (publ) it is kr 3.88 per share (as of Nov 10, 2026), against a price of kr 4.60.
Is Gasporox AB (publ) stock overvalued or undervalued in 2026?
As of Nov 10, 2026, GPX trades above its calculated fair value: price kr 4.60, fair value kr 3.88, a gap of about −16% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GPX?
No. The price is what the market pays today (kr 4.60); the fair value is what the company's own numbers justify (kr 3.88). For Gasporox AB (publ) the two are kr 0.7200 per share apart. That gap is exactly why we show both numbers side by side.
How much is Gasporox AB (publ) worth?
The market values Gasporox AB (publ) at about 43.0M SEK (market capitalisation, as of Nov 10, 2026). Per share that is kr 4.60; our models calculate a fair value of kr 3.88 per share.
What do the bullish and bearish scenarios say about GPX?
Our models span a range for Gasporox AB (publ): cautious scenario kr 2.91, base kr 3.88, optimistic kr 4.85 per share (as of Nov 10, 2026, price kr 4.60). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Gasporox AB (publ) (GPX)?
Balance-sheet figures for Gasporox AB (publ) (as of Nov 10, 2026): return on equity −48.3%, debt of 0.73 per unit of equity. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is GPX from its 52-week high?
Gasporox AB (publ) trades at kr 4.60, about 50% below its 52-week high of kr 9.15 and 5% above the low of kr 4.40 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of kr 3.88 is for.
Which stocks are comparable to Gasporox AB (publ)?
From the same area (Technology) we also value Keysight Technologies, Inc, Garmin Ltd, Coherent Corp, Teledyne Technologies Incorporated, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Gasporox AB (publ) stock attractive at the current price?
The data as of Nov 10, 2026: price kr 4.60, calculated fair value kr 3.88 (−16%), Quality Score 27/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Gasporox AB (publ) itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Gasporox AB (publ) (GPX)?
The closing price on Nov 10, 2026 was kr 4.60. Our estimate is kr 3.88, about 16% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Gasporox AB (publ) right now?
Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Gasporox AB (publ)

How large is the market capitalisation of Gasporox AB (publ) (GPX)?
The market capitalisation of Gasporox AB (publ) is 43.0M SEK (≈ $4.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Gasporox AB (publ) (GPX)?
The price-to-sales ratio of Gasporox AB (publ) is 1.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Gasporox AB (publ) (GPX)?
Earnings per share at Gasporox AB (publ) are kr −0.7300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Gasporox AB (publ) (GPX)?
The net margin of Gasporox AB (publ) is −18.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Gasporox AB (publ) (GPX)?
The return on equity (ROE) of Gasporox AB (publ) is −48.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Gasporox AB (publ) (GPX)?
On an EBIT basis the return on assets of Gasporox AB (publ) is −9.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Gasporox AB (publ) (GPX)?
The operating margin of Gasporox AB (publ) is −66.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Gasporox AB (publ) (GPX)?
Revenue at Gasporox AB (publ) is growing −34.7% versus a year earlier (3y avg +13.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Gasporox AB (publ) (GPX)?
Earnings per share at Gasporox AB (publ) are growing −98.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Gasporox AB (publ) (GPX) generate?
The free cash flow of Gasporox AB (publ) is −4.7M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Gasporox AB (publ) (GPX) hold?
Gasporox AB (publ) holds more cash than debt, 6.7M SEK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Gasporox AB (publ) in the live analysis

One click puts Gasporox AB (publ) on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.